Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 20CNS 5Tumor-Agnostic 3Other solid neoplasm 3Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Neoplasms 3

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Ketoconazole × Tumor-Agnostic × Clear all
NCT03471364 2025-10-08

Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash

Mayo Clinic

Phase EARLY_PHASE1 Completed
58 enrolled
Tumor-Agnostic

Neoplasms

NCT00586898 2016-03-25

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
36 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT01548170 2012-03-08

To Assess the Interaction Between Sunitinib and Ketoconazole to Reduce the Dose and Cost of Sunitinib

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Phase 1 Completed
12 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡